Karolina
banner
kszczepanik.bsky.social
Karolina
@kszczepanik.bsky.social
Pharmacist | Clinical Trials | Clinical Trial Manager | Tennis | Books | 🇵🇱🇪🇺
From early experiments to modern concept of clinical trials: A journey💡
In the world of clinical trials, history tells a fascinating story, starting with James Lind’s groundbreaking experiment in 1747. Despite not fitting the modern definition, Lind's work was a pivotal step in medical research.🧵
December 7, 2024 at 7:11 PM
Over the past 5 years, increasing numbers of drugs 💊 and vaccines 💉 have been discovered with AI.
If you’re wondering what is the success rate of AI-discovered drugs, you should definitely refer to enclosed below publication and graphs. 📈

Read more:
www.sciencedirect.com/science/arti...
November 23, 2024 at 2:59 PM
Jak wynika z najnowszego raportu IQVIA dla EFPIA i Vaccines Europe: Polska pod względem liczby badań klinicznych znalazła się w pierwszej piątce krajów EOG, odnotowując w latach 2018-2023 jedynie 2% spadek, który dla całego EOG wynosi 6%.🧵

📊 Pełny raport ENG
www.efpia.eu/media/0ipkat...
www.efpia.eu
November 21, 2024 at 12:07 PM
Reposted by Karolina
More than half of all US adults are eligible for semaglutide for diabetes management, weight management, and cardiovascular disease. #AHA24

https://ja.ma/3YUKDwf
November 18, 2024 at 7:50 PM
As we are all aware patient recruitment is challenging for clinical trials. TrialGPT has been introduced as a novel architecture that uses large language models to perform patient-trial matching. For more details follow the link.

www.nature.com/articles/s41...
Matching patients to clinical trials with large language models - Nature Communications
Patient recruitment is challenging for clinical trials. Here, the authors introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models.
www.nature.com
November 18, 2024 at 8:07 PM
It’s absolutely refreshing to see interesting feed again. Hate has been muted and it seems 🦋 has managed to celebrate differences instead of belittling them.
November 17, 2024 at 5:40 PM